Phibro Animal Health CorpNASDAQ:PAHC
- LAST PRICE12.7300
- TODAY'S CHANGE (%)0.2900 (2.3312%)
- Bid / Lots12.2900/ 1
- Ask / Lots13.4700/ 1
- Open / Previous Close12.4100 / 12.4400
- Day Range
- 52 Week Range
- Volume76,507
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PAHC |
|---|---|---|
| 09:32 ET | 434 | 12.41 |
| 09:34 ET | 1924 | 12.5094 |
| 09:41 ET | 100 | 12.48 |
| 09:50 ET | 902 | 12.59 |
| 09:54 ET | 130 | 12.4981 |
| 09:56 ET | 200 | 12.64 |
| 10:06 ET | 100 | 12.7 |
| 10:08 ET | 300 | 12.64 |
| 10:14 ET | 100 | 12.62 |
| 10:19 ET | 100 | 12.625 |
| 10:24 ET | 600 | 12.6 |
| 10:28 ET | 100 | 12.55 |
| 10:32 ET | 200 | 12.57 |
| 10:33 ET | 200 | 12.58 |
| 10:48 ET | 8733 | 12.49 |
| 11:00 ET | 100 | 12.64 |
| 11:04 ET | 100 | 12.61 |
| 11:06 ET | 100 | 12.65 |
| 11:08 ET | 100 | 12.66 |
| 11:09 ET | 100 | 12.63 |
| 11:11 ET | 900 | 12.62 |
| 11:13 ET | 300 | 12.63 |
| 11:18 ET | 200 | 12.64 |
| 11:22 ET | 452 | 12.61 |
| 11:27 ET | 200 | 12.65 |
| 11:29 ET | 300 | 12.62 |
| 11:33 ET | 100 | 12.65 |
| 12:00 ET | 100 | 12.66 |
| 12:21 ET | 900 | 12.69 |
| 12:25 ET | 100 | 12.72 |
| 12:41 ET | 100 | 12.74 |
| 12:43 ET | 800 | 12.73 |
| 12:50 ET | 100 | 12.745 |
| 12:56 ET | 100 | 12.76 |
| 01:03 ET | 1799 | 12.79 |
| 01:06 ET | 1768 | 12.7701 |
| 01:08 ET | 100 | 12.79 |
| 01:12 ET | 100 | 12.79 |
| 01:17 ET | 100 | 12.81 |
| 01:26 ET | 300 | 12.75 |
| 01:33 ET | 100 | 12.74 |
| 01:44 ET | 200 | 12.76 |
| 01:48 ET | 100 | 12.755 |
| 02:02 ET | 128 | 12.788 |
| 02:13 ET | 100 | 12.77 |
| 02:27 ET | 466 | 12.7906 |
| 02:31 ET | 1472 | 12.79 |
| 02:42 ET | 400 | 12.82 |
| 02:45 ET | 100 | 12.8 |
| 02:47 ET | 100 | 12.8 |
| 03:03 ET | 500 | 12.81 |
| 03:07 ET | 300 | 12.8 |
| 03:09 ET | 100 | 12.79 |
| 03:14 ET | 100 | 12.78 |
| 03:18 ET | 100 | 12.76 |
| 03:23 ET | 100 | 12.76 |
| 03:32 ET | 300 | 12.75 |
| 03:34 ET | 300 | 12.76 |
| 03:45 ET | 600 | 12.74 |
| 03:48 ET | 700 | 12.75 |
| 03:52 ET | 497 | 12.73 |
| 03:54 ET | 700 | 12.73 |
| 03:56 ET | 400 | 12.74 |
| 03:57 ET | 500 | 12.73 |
| 03:59 ET | 400 | 12.73 |
Apr 18, 2024
Press Release: Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Results, from 5:03PM ET on Thursday Apr 18, 2024 by Dow Jones
5:03PM ET on Thursday Apr 18, 2024 by Dow JonesPhibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Results, from 4:00PM ET on Thursday Apr 18, 2024 by Dow Jones
4:00PM ET on Thursday Apr 18, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Phibro Animal Health Corp | 515.6M | 34.8x | -13.61% |
PetIQ Inc | 491.2M | 269.3x | --- |
Supernus Pharmaceuticals Inc | 1.6B | -1,980.9x | -59.02% |
Eagle Pharmaceuticals Inc | 54.0M | 4.6x | -4.75% |
Medicine Man Technologies Inc | 48.5M | -0.4x | --- |
Shengtai Pharmaceutical Inc | 10.0 | 0.0x | --- |
Company Information
Phibro Animal Health Corporation is a diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 770 product lines in over 80 countries to approximately 4,000 customers. The Company has three segments. Animal Health segment develops, manufactures and markets about 270 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. Mineral Nutrition segment manufactures and markets approximately 420 formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries, predominantly in the United States.
Contact Information
- Headquarters
- 300 Frank W. Burr Blvd. Suite 21, 65 Challenger RoadTEANECK, NJ, United States 07666
- Phone
- 201-329-7300
- Fax
- 302-655-5049
Executives
- Chairman of the Board, President, Chief Executive Officer
- Jack Bendheim
- Chief Financial Officer
- Glenn David
- Director, President of MACIE Region and General Manager of Israel Operations
- Jonathan Bendheim
- President, North America Region
- Rob Aukerman
- Chief Operating Officer
- Larry Miller
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $515.6M |
|---|---|
Revenue (TTM) | $982.0M |
Shares Outstanding | 40.5M |
Dividend Yield | 3.77% |
Annual Dividend Rate | 0.4800 USD |
Ex-Dividend Date | 03-05-24 |
Pay Date | 03-27-24 |
Beta | 0.73 |
EPS | $0.37 |
Book Value | $6.97 |
P/E Ratio | 34.8x |
Price/Sales (TTM) | 0.5 |
Price/Cash Flow (TTM) | 10.4x |
Operating Margin | 5.83% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
